ARTICLE | Company News
Management tracks: bluebird, Sangamo
February 15, 2018 10:33 PM UTC
Gene therapy company bluebird bio Inc. (NASDAQ:BLUE) promoted Alison Finger to chief commercial officer from SVP of marketing and product launch.
Gene editing company Sangamo Therapeutics Inc. (NASDAQ:SGMO) hired Heather Turner as SVP and general counsel. She was EVP and general counsel at Atara Biotherapeutics Inc. (NASDAQ:ATRA)...